Mohnark Lidocaine 4% Topical Anesthetic Cream Recalled for Non-Child-Resistant Packaging
Mohnark Pharmaceuticals is recalling Lidocaine 4% Topical Anesthetic Cream because the packaging does not meet child-resistant requirements, creating a poisoning risk if young children ingest the product. About 9,000 units sold online were affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This recall involves a product that poses a direct risk of harm to children through poisoning if ingested. Although no illnesses have been reported, the hazard is high-risk and targets a vulnerable population. The rubric indicates that risk-of-harm products where injury has not yet been reported score as High (3).
Plain-English summary
Mohnark Pharmaceuticals Inc. of Davie, Florida is recalling Lidocaine 4% Topical Anesthetic Cream sold online through Amazon.com and Walmart.com from January 2021 through January 2022. The product was distributed in a white tube with a flip-top closure bearing the Mohnark Pharmaceuticals logo.
The recalled product does not have child-resistant packaging as required by the Poison Prevention Packaging Act. Lidocaine is a controlled substance that poses a risk of poisoning if ingested by young children. Affected lot codes are 01202201, 210201, 210301, 210503, 210505, 210601, 211002, and 210401. The UPC is 860002324906.
No injuries or illnesses have been reported. Consumers should immediately stop using the product and store it out of sight and reach of children. Contact Mohnark Pharmaceuticals at 866-611-5206 (9 a.m. to 4 p.m. ET, Monday through Friday) or visit www.mohnark.com and click "RECALL" for disposal instructions and refund information. The company is contacting all known purchasers directly.
The recalled product
- Product
- Lidocaine 4% Topical Anesthetic Cream
- Manufacturer
- Mohnark Pharmaceuticals Inc., of Davie, Fla.
- Category
- Drug — Topical Anesthetic
- Hazard
- child-resistant-packaging-failure
- poisoning-risk
- Affected units
- 9,000
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 860002324906
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateMedline Ophthalmic Pack with Lidocaine Injection Kits Recalled
FDA (Devices) · 2026-07-08
- SevereAccucaine Lidocaine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Sterile Solution Lacks Assurance of Sterility
FDA (Drugs) · 2026-07-08
- SevereChloraPrep One-Step Antiseptic Applicators recalled for lack of sterility assurance
FDA (Drugs) · 2026-07-08